Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

MiniVax wins $20,000 in NOBIC’s second annual BioChallenge business competition

MiniVax, Inc. (MiniVax) participated in the New Orleans BioInnovation Center's (NOBIC) second annual BioChallenge, a business competition part of the three-day Innovation Louisiana 2013 conference.

3 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Newly identified protein could prove promising new drug target for AIDS

Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

2 Dec 2013

Vitamin D status optimization could cut pneumonia cases

A large US population-based study confirms that serum 25-hydroxyvitamin D levels are associated with the risk for community-acquired pneumonia.

2 Dec 2013

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.

2 Dec 2013

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

2 Dec 2013

Food safety tips for people with HIV/AIDS

December 1, 2013 is World AIDS Day and while the connection between HIV/AIDS (Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome) and food safety may not seem obvious, it's actually crucial.

30 Nov 2013

Researchers identify gene responsible for malfunctions in fear-related memory system

A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.

29 Nov 2013

Medical Research Council should do more in the development of gold standard for clinical trial design

More should be done to celebrate the role of one of Britain’s leading institutions, the Medical Research Council, in the development of the gold standard for clinical trial design. Sir Iain Chalmers, writing in the Journal of the Royal Society of Medicine, questions the apparent reluctance of the MRC to take credit for its ground-breaking work in the design and management of randomised multicentre controlled clinical trials in the 1950s.

28 Nov 2013

State highlights: S.C. clinic a model for free care; Mont. doctor's push to treat mine workers sickened by asbestos; fast food consumption in Calif. kids

What began two decades ago on Hilton Head Island as a free clinic using retired physicians and volunteers to care for the working poor has become a model for dozens of similar clinics nationwide. At a time when the nation debates how to pay for care, there are now 96 Volunteers in Medicine Clinics in 29 states (Smith, 11/27).

28 Nov 2013

Walk-in clinics staffed by nurses can reduce health care costs, says URI professor

People who don't have health insurance are often forced to seek treatment at hospital emergency rooms for colds, body aches and other routine illnesses. Those visits cost patients, hospitals and taxpayers millions of dollars every year.

28 Nov 2013

How Washington State made its health insurance exchange work; Philly plans big exchange push

It was on a cold, sunny day in Baltimore last January that Curt Kwak, chief information officer of the Washington Health Benefit Exchange, first realized that the signature feature of President Obama's Affordable Care Act could be in trouble.

28 Nov 2013

Loyola dermatologist offers skin care tips for holidays

The holidays often bring freezing temperatures, limited sleep, sugary treats and cocktails. This combination can spell trouble for your skin, according to a dermatologist at Loyola University Health System.

28 Nov 2013

New NIH guidelines for managing opportunistic infections in children with HIV

Sharon Nachman, MD, a pediatric HIV and infectious diseases specialist at Stony Brook Children's Hospital, is a co-author of new National Institutes of Health (NIH)-issued guidelines for the prevention, treatment and management of opportunistic infections in HIV-exposed and HIV-infected children. The 2013 guidelines shed light on the most effective way to treat dangerous and deadly infections such as pneumonia or tuberculosis that can strike immunosuppressed pediatric HIV patients.

27 Nov 2013

First Edition: Nov. 27, 2013

Kaiser Health News staff writer Phil Galewitz, in collaboration with McClatchy, reports: "Like half the states, South Carolina chose not to expand Medicaid under the federal health law next year, citing the program's high costs and inefficiency. Yet, state officials still forecast a 16 percent enrollment jump by the end of June, 2015, triple that of a typical year and even higher than the 12 percent average increase expected in states that are expanding eligibility.

27 Nov 2013

University of Wisconsin Hospital and Clinics recognized with 2013 Partnership in Prevention Award

The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the University of Wisconsin Hospital and Clinics (UWHC) with the 2013 Partnership in Prevention Award for achieving sustainable improvements towards eliminating healthcare-associated infections (HAIs).

27 Nov 2013

Typhoon survivors in Tacloban vaccinated against measles and polio

Children in Tacloban – the city hit hardest by Typhoon Haiyan – were vaccinated against measles and polio in the first phase of a mass campaign by the Government of the Philippines with support from UNICEF, the World Health Organization, and other partners. They also received Vitamin A supplements to help improve their immunity against infections.

27 Nov 2013

WHO releases new treatment guidelines for children suffering severe acute malnutrition

WHO today released new treatment guidelines for the almost 20 million children under-five worldwide who have severe acute malnutrition.

27 Nov 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

MiniVax wins $20,000 in NOBIC’s second annual BioChallenge business competition

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Newly identified protein could prove promising new drug target for AIDS

Vitamin D status optimization could cut pneumonia cases

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

New biomarkers to improve diagnostics of prostate cancer

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Food safety tips for people with HIV/AIDS

Researchers identify gene responsible for malfunctions in fear-related memory system

Medical Research Council should do more in the development of gold standard for clinical trial design

State highlights: S.C. clinic a model for free care; Mont. doctor's push to treat mine workers sickened by asbestos; fast food consumption in Calif. kids

Walk-in clinics staffed by nurses can reduce health care costs, says URI professor

How Washington State made its health insurance exchange work; Philly plans big exchange push

Loyola dermatologist offers skin care tips for holidays

New NIH guidelines for managing opportunistic infections in children with HIV

First Edition: Nov. 27, 2013

University of Wisconsin Hospital and Clinics recognized with 2013 Partnership in Prevention Award

Typhoon survivors in Tacloban vaccinated against measles and polio

WHO releases new treatment guidelines for children suffering severe acute malnutrition

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in